| Precision Assignment of Intervention Messages to Promote Physical Activity - Precision AIM (NCT04972279) | Penn State University | 2022-01-02 |
| To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer (NCT05198531) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-01-01 |
| This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions (NCT03939364) | Skyline Biosciences | 2022-01-01 |
| Clinical Trial of BAO-G Technique in Complex Aortic Aneurysm Endovascular Repair (BAO-G-02) (NCT07141251) | Peking Union Medical College Hospital | 2022-01-01 |
| Comparative Study Between the Roles of Intrauterine Misoprostol Versus the Sublingual Route for Prevention of Postpartum Blood Loss in Elective Cesarean Sections (NCT06364098) | Cairo University | 2022-01-01 |
| UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors (NCT06760117) | Sun Yat-sen University | 2022-01-01 |
| Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody Cocktail (NCT05157997) | Northwell Health | 2022-01-01 |
| Improvement of Peritoneal Catheter Placement in VPS With a Splitable Trocar (NCT05476874) | Southern Medical University, China | 2022-01-01 |
| Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid Tumors (NCT05181865) | Flame Biosciences | 2022-01-01 |
| The Protective Effect of Prostaglandin on Coronary Microcirculation and Ventricular Remodeling After Reperfusion Therapy in Acute ST-segment Elevation Myocardial Infarction (NCT05043558) | Shenzhen People's Hospital | 2022-01-01 |
| Almonertinib in the First-line Treatment of Patients of NSCLC With Poor Performance Status (NCT05826483) | Guangzhou Institute of Respiratory Disease | 2022-01-01 |
| Role of Montelukast in the Management of Chronic Rhinosinusitis With Nasal Polyps. (NCT05143502) | Assiut University | 2022-01-01 |
| Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients (NCT04323475) | Precisio Biotix Therapeutics, Inc. | 2022-01-01 |
| Testing the Efficacy of a Mindfulness- and Acceptance-Based Smartphone App for PTSD: A Randomized Controlled Trial (NCT04861311) | University of Nevada, Las Vegas | 2022-01-01 |
| Individualized Response-adaptive Radiation Dose Prescription in HNC Based on MRI (NCT05160714) | University Hospital Tuebingen | 2022-01-01 |
| A Study to Investigate the Safety and Efficacy of Ricolinostat (NCT05229042) | Beijing 3E-Regenacy Pharmaceuticals Co., Ltd. | 2022-01-01 |
| Comparisons Between Dexmedetomidine and Magnesium Sulfate in Controlled Hypotension During Rhinoplasty Surgeries (NCT05880693) | mohamed | 2022-01-01 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Tourette Syndrome (NCT05158439) | The Foundation for Orthopaedics and Regenerative Medicine | 2022-01-01 |
| Effect of Phenytoin Cream on Wound Healing After Anal Fissure Surgery. (NCT06633185) | Mansoura University | 2022-01-01 |
| Proteomic Study of Chuanhong Zhongfeng Capsule in the Treatment of ACI (NCT06874140) | Yingyue Ding | 2022-01-01 |
| Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid (NCT05578820) | Gene Surgery LLC | 2022-01-01 |
| Belimumab for Treatment of cGVHD Following Allo-HCT (NCT05604742) | xuna | 2022-01-01 |
| Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected Children (NCT05381363) | Children's Hospital of Fudan University | 2022-01-01 |
| Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid Stenting (NCT04091074) | Assiut University | 2022-01-01 |
| Inhaled NAC in Treatment of IPF (NCT03720483) | University of Colorado, Denver | 2022-01-01 |
| A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP) (NCT04751955) | Korean Cancer Study Group | 2022-01-01 |
| Propofol Versus Midazolam in Sedation for Upper and Lower Gastrointestinal Endoscopy. (NCT06358131) | Mansoura University | 2022-01-01 |
| Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer (NCT05588206) | First People's Hospital of Hangzhou | 2022-01-01 |
| A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab (NCT06225635) | Shin Poong Pharmaceutical Co. Ltd. | 2022-01-01 |
| Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection (NCT02346617) | Yae-Jean Kim | 2022-01-01 |
| Phase I/II Clinical Trial of NP41 for Cranial Nerve Fluorescence Imaging (NCT05043519) | Peking University Third Hospital | 2022-01-01 |
| Efficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological Cancer (NCT05152797) | Women's Hospital School Of Medicine Zhejiang University | 2022-01-01 |
| Food-effect Bioavailability of Gemigliptin and Dapagliflozin 50/10 mg (NCT05105698) | LG Chem | 2022-01-01 |
| Impact of CBD-Rich Oil on Aversive Memory Reconsolidation (NCT04726475) | University of Texas at Austin | 2022-01-01 |
| Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus (NCT04929626) | Ziauddin University | 2022-01-01 |
| A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma (NCT05201118) | Chunrui Li | 2022-01-01 |
| Roflumilast TMS-EEG Plasticity (NCT04369547) | University of Calgary | 2022-01-01 |
| Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors (NCT05117138) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2022-01-01 |
| Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer (NCT06391190) | RenJi Hospital | 2022-01-01 |
| Phage Therapy for the Prevention and Treatment of Pressure Ulcers. (NCT04815798) | Precisio Biotix Therapeutics, Inc. | 2022-01-01 |
| The Use of Expandeded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans (NCT04815213) | University of Jordan | 2022-01-01 |
| Recombinant Humanized Anti-CD47/PD-1 Bifunctional Antibody HX009 in Patients With Relapsed/Refractory Lymphoma (NCT05189093) | Hangzhou Hanx Biopharmaceuticals, Ltd. | 2021-12-31 |
| CO Monitoring for Tobacco Cessation in Quitlines (NCT05327660) | Consumer Wellness Solutions | 2021-12-31 |
| A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors (NCT05420545) | Chongqing Precision Biotech Co., Ltd | 2021-12-31 |
| A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer (NCT05226507) | Nuvectis Pharma, Inc. | 2021-12-31 |
| LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery (NCT04105062) | Washington University School of Medicine | 2021-12-31 |
| Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD (NCT05192122) | University of Illinois at Chicago | 2021-12-31 |
| A Study of SHR-A1921 for Injection in Subjects With Advanced Solid Tumours (NCT05154604) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2021-12-31 |
| Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury (NCT04194671) | Chinese PLA General Hospital | 2021-12-31 |
| Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma (NCT05155215) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2021-12-31 |
| Study of FCN-098 in Patients With Advanced Solid Tumor (NCT05212987) | Fochon Pharmaceuticals, Ltd. | 2021-12-31 |
| Anti-FLT3 CAR T-cell Therapy in FLT3 Positive Relapsed/Refractory Acute Myeloid Leukemia (NCT05023707) | The First Affiliated Hospital of Soochow University | 2021-12-31 |
| Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer (NCT05420519) | Chongqing Precision Biotech Co., Ltd | 2021-12-31 |
| A Safety, Tolerability, and Efficacy Study of IBI314 in Patients With Mild to Moderate COVID-19 (NCT05172141) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-12-31 |
| Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers (NCT04611139) | HonorHealth Research Institute | 2021-12-31 |
| Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of CT1812 in Healthy Adult Male Subjects (NCT05225389) | Cognition Therapeutics | 2021-12-31 |
| CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas (NCT05128786) | Shanghai PerHum Therapeutics Co., Ltd. | 2021-12-30 |
| A Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of DBPR108 Tablets in Type 2 Diabetes Mellitus Patients (NCT05146869) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-12-30 |
| A Study Comparing Four Different Rivoceranib Tablets in Healthy Participants (NCT05287360) | Elevar Therapeutics | 2021-12-30 |
| A Study of Single Drug TJ011133 and Toripalimab Combine Treatment for Advanced Solid Tumor (NCT05148533) | TJ Biopharma Co., Ltd. | 2021-12-30 |
| Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA) (NCT05197530) | University of Rochester | 2021-12-30 |
| A Study to Evaluate the Safety, Tolerability, and PK Profile of Single and Multiple Doses TJ202 in Patient With Systemic Lupus Erythematosus (NCT05140824) | TJ Biopharma Co., Ltd. | 2021-12-30 |
| Food Effect on Pharmacokinetic Profiles of VV116 Administered Orally to Chinese Healthy Volunteers (NCT05221138) | Vigonvita Life Sciences | 2021-12-30 |
| A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies (NCT05055791) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-12-29 |
| Phase I Clinical Study of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defect (NCT07132437) | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | 2021-12-29 |
| Evaluation of Pharmacokinetic and Safety of NVP-1705 and NVP-1705-R in Healthy Subjects (NCT05141110) | NVP Healthcare | 2021-12-29 |
| Study of Turning Point Therapeutics LM-302 in Patients With Advance Solid Tumors (NCT05001516) | Turning Point Therapeutics, Inc. | 2021-12-29 |
| ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization (NCT05198102) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-12-29 |
| Pharmacokinetics of CVL-231 Following Single Oral Administration of Modified- and Immediate-release Formulations in Fasted and Fed Healthy Participants (NCT05106309) | Cerevel Therapeutics, LLC | 2021-12-29 |
| A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies (NCT05199272) | 23andMe, Inc. | 2021-12-29 |
| A Bridging Study of FB2001 in Healthy Subjects (NCT05197179) | Frontier Biotechnologies Inc. | 2021-12-29 |
| Actium-225-Prostate Specific Membrane Antigen Imaging & Therapy (NCT05902247) | Erasmus Medical Center | 2021-12-29 |
| Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating CEA Positive Rectal Cancer (NCT02403505) | Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair | 2021-12-28 |
| A Study Evaluating the Safety, Tolerability and Preliminary Efficacy of IBI322 in Subjects With Myeloid Tumor (NCT05148442) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-12-28 |
| NK Cell Therapy for AML (NCT05256277) | Zhejiang University | 2021-12-28 |
| HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study (NCT05167071) | Harbour BioMed (Guangzhou) Co. Ltd. | 2021-12-28 |
| A Study of HRS2543 in Patients With Advanced Tumors (NCT05068856) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2021-12-28 |
| A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults (NCT05164094) | ModernaTX, Inc. | 2021-12-28 |
| Carfilzomib and Belatacept for Desensitization (NCT05017545) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-12-28 |
| A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors (NCT05125523) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-12-28 |
| A Study to Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer (NCT04813107) | Jiangsu Yahong Meditech Co., Ltd aka Asieris | 2021-12-28 |
| A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical Cream (NCT05514353) | Pyramid Biosciences | 2021-12-28 |
| A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy (NCT05160415) | Edgewise Therapeutics, Inc. | 2021-12-28 |
| Norovirus Challenge Study (NCT05212168) | Vaxart | 2021-12-27 |
| Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative (NCT05153343) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2021-12-27 |
| Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia (NCT04925479) | Novartis Pharmaceuticals | 2021-12-27 |
| Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma (NCT04782609) | Samus Therapeutics, Inc. | 2021-12-27 |
| Effect of Omeprazole on the Pharmacokinetics of SHR6390 in Healthy Subjects (NCT04989829) | Jiangsu HengRui Medicine Co., Ltd. | 2021-12-27 |
| The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions (NCT05104424) | Ministry of Health, Saudi Arabia | 2021-12-26 |
| An Evaluation of LY007 Cell Injection for r/r B-NHL (NCT06364852) | Ruijin Hospital | 2021-12-25 |
| An Evaluation of LY007 Cell Injection for r/r B-NHL (NCT06279611) | Shanghai Longyao Biotechnology Inc., Ltd. | 2021-12-25 |
| JMT101 Combined With Afatinib in Patients With Advanced Esophageal Squamous Cell Carcinoma After Standard Therapy (NCT05164848) | Peking University | 2021-12-25 |
| Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 With and Without Ticagrelor Pretreatment in Chinese Healthy Volunteers (NCT05162131) | SFJ Pharmaceuticals, Inc. | 2021-12-25 |
| Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China (NCT05105971) | Bio-Thera Solutions | 2021-12-23 |
| PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer (NCT04768608) | Zhejiang University | 2021-12-23 |
| Anti-CD33 CAR NK Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (NCT05008575) | Xinqiao Hospital of Chongqing | 2021-12-23 |
| A Study of ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors (NCT05075564) | Elpiscience Biopharma, Ltd. | 2021-12-23 |
| First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors (NCT05103046) | 1200 Pharma, LLC | 2021-12-23 |
| Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants (NCT04939701) | Astellas Pharma Global Development, Inc. | 2021-12-23 |
| APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma (NCT04942067) | Ascentage Pharma Group Inc. | 2021-12-23 |